Final Countdown: San Francisco Set to Host B2B’s Boldest Voices at Marketers Connect

Final Countdown: San Francisco Set to Host B2B's Boldest Voices at Marketers Connect Join industry experts from Autodesk, Suki AI, and Onix at this high-impact B2B event hosted by Vereigen Media. GlobeNewswire August 08, 2025 AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) — Just one week away! San Francisco will be the epicenter of B2B […]

Secret DUO Now Available at South Jersey Skin Care

MOUNT LAUREL, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) — South Jersey Skin Care & Laser Center is thrilled to introduce Secret DUO at their New Jersey practice, a high-tech skin rejuvenation treatment that delivers microneedling, radiofrequency energy, and a laser treatment at the same time to revitalize your skin. Through the combination of two powerful

Secret DUO Now Available at South Jersey Skin Care

Secret DUO Now Available at South Jersey Skin Care The New Jersey-Based Dermatology Team Introduces an Advanced RF Microneedling and Laser Energy Treatment This Summer GlobeNewswire August 08, 2025 MOUNT LAUREL, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) — South Jersey Skin Care & Laser Center is thrilled to introduce Secret DUO at their New Jersey

ITSM Software Considered Strategic Priority for Organizations in 2025: Info-Tech Research Group Identifies the Top Nine Providers Ranked by SoftwareReviews Users in Annual Report

The recently published 2025 IT Service Management (ITSM) Emotional Footprint report from global IT research and advisory firm Info-Tech Research Group highlights the top ITSM solutions that help organizations improve service delivery and support business growth. The annual report's insights are based on feedback from users on the firm's SoftwareReviews platform. Info-Tech Research Group has

USX Cyber(R) Launches Integrated Application Control Module in GUARDIENT(R) Platform

VIENNA, Va., Aug. 08, 2025 (GLOBE NEWSWIRE) — USX Cyber(R), a leading innovator in cybersecurity and compliance automation, proudly announces the release of its new in-house Application Control module–a powerful enhancement to its flagship GUARDIENT(R) platform. Built for both end-user simplicity and enterprise-grade remote management, the new feature redefines how organizations control what runs on

USX Cyber(R) Launches Integrated Application Control Module in GUARDIENT(R) Platform

USX Cyber(R) Launches Integrated Application Control Module in GUARDIENT(R) Platform GlobeNewswire August 08, 2025 VIENNA, Va., Aug. 08, 2025 (GLOBE NEWSWIRE) — USX Cyber(R), a leading innovator in cybersecurity and compliance automation, proudly announces the release of its new in-house Application Control module–a powerful enhancement to its flagship GUARDIENT(R) platform. Built for both end-user simplicity

First Horizon CFO Named to Super Women in Business Class of 2025

First Horizon Corporation (NYSE: FHN or “First Horizon”)is proud to announce that Senior Executive Vice President and Chief Financial Officer Hope Dmuchowski has been named to theMemphis Business Journal's Super Women in Business Class of 2025. https://mma.prnewswire.com/media/2747044/First_Horizon_Hope_Dmuchowski_2025.jpg This honor celebrates high-achieving women in the Memphis business community who have made significant contributions in their fields

Saputo Announces Election of Directors

(TSX:SAP), MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) announces that the nominees listed in the management information circular dated June 5, 2025, were elected as directors of Saputo at the annual meeting of shareholders held on August 8, 2025. Each of the following ten nominees proposed by

Saputo Announces Election of Directors

Saputo Announces Election of Directors GlobeNewswire August 08, 2025 MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) announces that the nominees listed in the management information circular dated June 5, 2025, were elected as directors of Saputo at the annual meeting of shareholders held on August 8, 2025.

U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS(R) as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

This press release is not intended for UK media. HERNEXEOS(R) (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial1 Accelerated approval follows Priority Review and Breakthrough Therapy Designation granted by the U.S. FDA for the treatment of patients with HER2 (ERBB2)-mutant advanced non-small cell

Scroll to Top